Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


The Path to Progress

At the crossroad between epigenetics and protein homeostasis, the cellular roles of ubiquitin proteasome pathways are emerging as very attractive targets for novel drug discovery opportunities in many therapeutic disease indications

Xavier Jacq and Niall Martin, MISSION Therapeutics, (December 2013)

Keywords: Ubiquitin pathways, Deubiquitylating enzyme (DUB), DNA damage response (DDR)

    View full article    |    Back to Discovery Technology section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |